Overview:
Conventional wound healing turns out unproductive in healing acute wounds such as deep cuts, burn injuries, and chronic ulcers. Introduction of bioactive wound care products has efficiently provided solution to treat such critical wounds and injuries. Bioactive wound dressings control infection and hasten healing process, reduce the risk of leakage, alleviate pain and discomfort. Materials such as chitosan, alginates, keratin, hydrocolloids and collagen are often the key constituents of bioactive wound dressings. Bioactive wound care is a new, yet flourishing market, where phenomenal demand for these products is being witnessed across both developed and developing markets.
In the overall bioactive wound dressings market, the demand for antimicrobial wound dressings is currently the highest die to their ability to fight infections thus hasten the healing process. Antimicrobial dressings are being widely used in burn treatment. Come of the most common antimicrobial dressings used are silver-coated dressings and cadexomer dressings. Novel antimicrobial products including activated charcoal and polyhexamethylene biguanide hydrochloride serve better to patients allergic to silver. Hence, growing adoption of antimicrobial dressings will drive the overall bioactive wound dressings market. Some other prominent drivers of this market include augmenting senescent patient pool and high prevalence of diabetic ulcers. Negative pressure wound dressings, semi-permeable, transparentand foam dressings are the chief competitors to bioactive wound care products.
The global bioactive wound care market is segmented on the following bases:
Key players identified for bioactive wound dressings market include but are not limited to:
Covidien plc, Coloplast A/S, Paul Hartmann AG, Systagenix Wound Management Ltd. Organogenesis, Inc., Covalon Technologies and severalothers
This report offers:
